Cancercenter.com:443 - St. Elizabeth Healthcare to open doors of new Cancer Center …

Provided by Alexa ranking, cancercenter.com:443 has ranked N/A in N/A and 536,926 on the world. cancercenter.com:443 reaches roughly 5,862 users per day and delivers about 175,873 users each month. The domain cancercenter.com:443 uses a Commercial suffix and it's server(s) are located in N/A with the IP number N/A and it is a .com:443 domain.

Web1 day ago · St. Elizabeth Healthcare will officially open the doors of the St. Elizabeth Cancer Center-Dearborn on Monday, April 29, providing cutting-edge cancer care and easier access to cancer screenings, prev

Search Results related to cancercenter.com:443 on Search Engine

St. Elizabeth Healthcare to open doors of new Cancer Center …
nkytribune.com

https://nkytribune.com/2024/04/st-elizabeth-healthcare-to-open-doors-of-new-cancer-center-dearborn-in-southeastern-indiana/

Web1 day ago · St. Elizabeth Healthcare will officially open the doors of the St. Elizabeth Cancer Center-Dearborn on Monday, April 29, providing cutting-edge cancer care and easier access to cancer screenings, prev

DA: 33 PA: 24 MOZ Rank: 74

NIH researchers develop AI tool with potential to more precisely …
nih.gov

https://www.nih.gov/news-events/news-releases/nih-researchers-develop-ai-tool-potential-more-precisely-match-cancer-drugs-patients

WebApr 18, 2024 · Media Advisory. Thursday, April 18, 2024. NIH researchers develop AI tool with potential to more precisely match cancer drugs to patients. Proof-of-concept study analyzed a newer technology known as single-cell RNA sequencing.

DA: 63 PA: 71 MOZ Rank: 41

Camrelizumab plus apatinib and SOX as first-line treatment in …
ascopubs.org

https://ascopubs.org/doi/10.1200/JCO.2024.42.3_suppl.351

WebJan 22, 2024 · 351 Background: Patients (pts) with AFP-producing G/GEJ adenocarcinoma generally respond poorly to first-line standard chemotherapy. We aimed to assess the efficacy and safety of first-line camrelizumab plus apatinib given concurrently with chemotherapy, followed by camrelizumab plus apatinib in AFP-producing G/GEJ adenocarcinoma pts. …

DA: 44 PA: 22 MOZ Rank: 44

Beyond weight loss: Bariatric surgery may reduce cancer risk
mayoclinic.org

https://cancerblog.mayoclinic.org/2024/04/23/beyond-weight-loss-bariatric-surgery-may-reduce-cancer-risk/

Web3 days ago · By Mayo Clinic staff. When you think about obesity, you may not connect it to cancer.However, researchers have long suspected a link between certain cancers and weight. Among those are endometrial, ovarian, colon, liver, pancreatic and postmenopausal breast cancers, which together contribute to 15 to 20% of all cancer deaths in the U.S.. Cancer …

DA: 85 PA: 70 MOZ Rank: 41

New study offers hope for a rare and devastating eye cancer
washingtonpost.com

https://www.washingtonpost.com/science/2024/04/22/rare-cancer-treatment-tcells-til/

Web3 days ago · The researchers in Pittsburgh tackled this problem in uveal melanoma, an eye cancer that afflicts only 5 people in a million, but that half the time spreads to other parts of the body, often the ...

DA: 68 PA: 61 MOZ Rank: 22

Expert consensus on multidisciplinary therapy of colorectal ... - PubMed
nih.gov

https://pubmed.ncbi.nlm.nih.gov/30764882/

WebFeb 14, 2019 · The lungs are the second most common site of metastasis for colorectal cancer (CRC) after the liver. Rectal cancer is associated with a higher incidence of lung metastases compared to colon cancer. In China, the proportion of rectal cancer cases is around 50%, much higher than that in Western countr …

DA: 90 PA: 70 MOZ Rank: 2

Improving cancer immunotherapy by prolonging T-cell survival
musc.edu

https://web.musc.edu/about/news-center/2024/04/22/prolonging-t-cell-survival

Web4 days ago · About the Author. Sarah Allen is a Master's student at MUSC and a science communications intern in the College of Graduate Studies. Categories: Cancer, Research. General MUSC Line 843-792-2300. Hollings researchers use patented technology to improve immunotherapy by prolonging survival of cancer-fighting T-cells.

DA: 2 PA: 65 MOZ Rank: 34

Student volunteers navigate cancer patients to resources through …
musc.edu

https://hollingscancercenter.musc.edu/news/archive/2024/04/22/student-volunteers-navigate-cancer-patients-to-resources-through-acs-cares

Web4 days ago · Navigating the challenges of cancer care isn’t easy. Besides the obvious medical challenges, there’s also all of the “other stuff” – transportation, child care, food insecurity, insurance coverage and more, all of which can ultimately affect a patient’s care.

DA: 69 PA: 53 MOZ Rank: 21

A Florida health provider says better building design can help …
usf.edu

https://health.wusf.usf.edu/health-news-florida/2024-04-22/a-florida-health-provider-says-better-building-design-can-help-patients-heal

Web3 days ago · The University of Miami Health System is finishing a 160,000-square-foot medical center in downtown Doral, slated to open in September 2024. The glass building will allow in natural light, expected to help patients. Instead of harsh fluorescent lighting, this glass-covered building will let in lots of natural light.

DA: 53 PA: 41 MOZ Rank: 29

A Phase Ib Dose Finding Study Assessing Safety and Activity of …
columbia.edu

https://www.cancer.columbia.edu/cancer-types-care/clinical-trials/find-clinical-trial/phase-ib-dose-finding-study-assessing-safety-and-activity-177lu-lu-dota-tate-newly-diagnosed-glioblastoma-combination-radiotherapy-or-without-temozolomide-and-recurrent-glioblastoma-single-agent

WebThe purpose of the study is to evaluate the safety of Lutathera alone in patients with recurrent glioblastoma and the combination of Lutathera with radiotherapy with temozolomide (TMZ) in patients with newly diagnosed glioblastoma (GB) and to establish the appropriate dose of this combination. Lutathera is a radioligand therapy, which is a targeted treatment that …

DA: 60 PA: 59 MOZ Rank: 2

Alexa Rank

GLOBAL RANK

536,926

Alexa Reach

0.0002587914

Page length

N/A

Alexa Rank Country N/A

N/A

Daily Unique Visitors

5,862

Monthly Unique Visitors

175,873

Vistor via Country

Country lang

Country code

Total visitor

Country

Country code

Total visitor

United States

37,619

Indonesia

29,424

Taiwan

9,568

United Kingdom

8,495

Brazil

7,686

Nigeria

6,718

Egypt

5,646

Hong Kong

5,329

Canada

5,329

Australia

4,643

Philippines

3,324

India

3,236

Malaysia

3,183

Spain

2,638

Germany

2,568

Mexico

2,462

France

2,322

Italy

2,146

Turkey

1,970

Iraq

1,794

Thailand

1,759

Netherlands

1,688

Israel

1,671

Cambodia

1,389

Algeria

1,073

Ireland

967

Romania

932

Jordan

862

Poland

827

Ghana

791

Argentina

756

South Africa

686

Belgium

616

Czechia

563

Ukraine

528

Japan

528

Morocco

510

South Korea

492

Lebanon

475

Saudi Arabia

457

Austria

440

Hungary

422

Sweden

405

Singapore

387

Pakistan

369

Bangladesh

352

Denmark

334

Greece

317

Alexa Traffic Graph

Alexa daily traffic trend graph

Alexa Statistics Graph for cancercenter.com:443

Alexa daily pageviews (percent) graph

Alexa Statistics Graph for www.nahklick.de

Alexa daily pageviews per user graph

Alexa time on site (in minutes) graph

Alexa bounce rate (percent) graph

Alexa search visits graph

SEOquake Zone

Title			Tips
Description			Tips
Keywords			Tips
Viewport			Tips
Icon
UTF-8

Mini site formation by Alexa Rank

MOZ Rank

DNS Record

Host	Type	Class	TTL	Extra

Hosting and Whois Zone

Domain infomation	Error: No appropriate Whois server found for cancercenter.com:443 domain!